Famous Patents
The first match was accidentally discovered in 1826 when John Walker scraped a stick with chemicals on the end against a stone floor.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6268011 | Composition and its use as a food supplement or for lowering lipids in serum A composition on basis of soybean ingredients contains (a) isolated soy protein, (b) soybean fibres, and optionally an additional protein source, a carbohydrate source, a fat source, flavouring agents, vitamins, minerals, electrolytes, trace elements and ... | 07/31/2001 |
| 6267952 | Lipase inhibiting polymers The invention features a method for treating obesity in a patient by administering to the patient a polymer that has been substituted with one or more groups that inhibit lipases, which are enzymes responsible for the hydrolysis of fat. The invention furt... | 07/31/2001 |
| 6224873 | Regulation of appetite, body weight and athletic function with materials derived from citrus varieties Materials derived from Citrus plants can be administered orally to humans for the purpose of producing or maintaining weight loss as well as for improving the person's physical performance and increasing the person's lean muscle mass. The Citrus materials... | 05/01/2001 |
| 6221838 | Methods of treating neuropeptide Y-associated conditions This invention describes methods of treating conditions associated with an excess of neuropeptide Y which comprises administering an analog of an obesity protein. This invention further describes methods of treating conditions associated with an excess of... | 04/24/2001 |
| 6214850 | Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof In accordance with the present invention, there is provided a class of compounds which are capable of modulating processes mediated by peroxisome proliferator activated receptor-gamma (PPAR-γ). The identification of such compounds makes it possible to in... | 04/10/2001 |
| 6162805 | Use of an NK-1 receptor antagonist and an SSRI for treating obesity The present invention relates to the use of an NK-1 receptor antagonist and a selective serotonin reuptake inhibitor for the treatment or prevention of obesity.... | 12/19/2000 |
| 6147108 | Method for treating type II diabetes mellitus A method for treating or preventing type II diabetes mellitus comprising administering an effective amount of a gastrointestinal lipase inhibitor, such as, tetrahydrolipstatin.... | 11/14/2000 |
| 6113949 | Weight control product and method of treating hyperlipidemia and increasing vigor with said product This invention relates to a weight control composition, preferably in the form of a capsule or tablet, comprising a mixture of guggul extract and at least one phosphate salt selected from calcium phosphate, potassium phosphate and sodium phosphate. The co... | 09/05/2000 |
| 6103737 | Aryl- and arylamino- substituted heterocycles as corticotropin releasing hormone antagonists Corticotropin releasing factor (CRF) antagonists of formula I: ##STR1## and their use in treating psychiatric disorders and neurological diseases, anxiety-related disorders, post-traumatic stress disorder, supranuclear palsy and feeding disorders as ... | 08/15/2000 |
| 6093743 | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor The present invention provides a novel dithiocarbamate disulfide dimer useful in various therapeutic treatments, either alone or in combination with other active agents. In one method, the disulfide derivative of a dithiocarbamate is coadministered with a... | 07/25/2000 |
| 6093403 | Sugar imbalance and diabetes treating herbal formulation An herbal formulation is disclosed for treating and preventing non-insulin dependent diabetes mellitus (NIDDM) and other sugar imbalances. The herbal formulation is added to the diet of a person suffering from NIDDM in a lectin mixture containing the herb... | 07/25/2000 |
| 6069176 | Phenylethanolamine compounds useful as ଲ 3 agonists, process for producing the same, and intermediates in the production of the same The present invention relates to phenylethanolamine compounds represented by general formula [I]: ##STR1## (where R1 represents hydrogen or halogen; R2 represents hydrogen, hydroxy, lower alkoxy, lower alkoxy substituted with on... | 05/30/2000 |
| 6048837 | OB polypeptides as modulators of body weight The present invention relates generally to the control of body weight of animals including mammals and humans, and more particularly to materials identified herein as modulators of body weight, and to diagnostic and therapeutic uses of such modulators. In... | 04/11/2000 |
| 6046184 | Medicament for treating obesity and improving lipid metabolism A medicament for preventive and therapeutic treatment of obesity and a disease with abnormal lipid metabolism which comprises as an active ingredient a compound selected from the group consisting of 24-alkylcholestan-3-ones and 24-alkylcholesten-3-ones su... | 04/04/2000 |
| 6028109 | Use of agonists of the peroxisome proliferator activated receptor alpha for treating obesity The use of agonists of the peroxisome proliferator activated receptor alpha (PPAR) for the manufacture of a medicament for the treatment of obesity and methods of treating obesity comprising the administration of a therapeutic amount of a PPAR ... | 02/22/2000 |
| 6025325 | Pegylated obese (ob) protein compositions Polyethylene and polypropylene protein conjugates which modulate body weight of animals and humans for the treatment, prevention and control of obesity and associated diseases or conditions, and the recombinant expression of these biologically active prot... | 02/15/2000 |
| 6025324 | Pegylated obese (ob) protein compositions Polyethylene and polypropylene protein conjugates which modulate body weight of ani is and humans for the treatment, prevention and control obesity and associated diseases or conditions, and the recombinant expression of these biologically active proteins... | 02/15/2000 |
| 6013622 | Method of regulating appetite and metabolism Methods and compositions capable of controlling weight in an animal, preferably a human, which methods involve administering diet compositions that modulate, and preferably reduce, synthesis and secretion of neuropeptide Y (NPY) and modulate, and preferab... | 01/11/2000 |
| 6008242 | Use of 1-centchroman for the manufacture of a pharmaceutical composition for the treatment of obesity The present invention provides novel uses of compounds of general formula I ##STR1## wherein R1, R4 and R5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lo... | 12/28/1999 |
| 5998457 | Creatine analogues for treatment of obesity The present invention relates to the use of creatine compounds for treating or preventing a metabolic disorder related to body weight control such as obesity, and it's associated diseases in a patient experiencing said disorder. The creatine compounds whi... | 12/07/1999 |
| 5980952 | Pharmaceutical composition for the programmed release of dexfenfluramine A novel pharmaceutical composition allowing the programmed release of dexfenfluramine containing a water-soluble acid addition salt of dexfenfluramine on a mixture of minigranules, both rapid release and slow release minigranules, permits the attainment o... | 11/09/1999 |
| 5976550 | Dietary food supplement A dietary food supplement for weight reduction formed of a mixture of a sugar based confectionary containing therapeutic amounts of chitosan, kava and a fat burning nutriceutical which may include choline/inusital, chromium picolinate, beta-hydroxy-beta-m... | 11/02/1999 |
| 5972974 | Transdermal nicotine metabolites and human body weight A therapeutic method is provided to manage human body weight in nicotine-experienced or nicotine-naive individuals, comprising of transdermally administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in ne... | 10/26/1999 |
| 5958885 | Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood The present invention relates to a peptide having an amino acid sequence of Val-Val-Tyr-Pro as well as an agent for inhibiting elevation of triglyceride levels in blood, a food for specified health use (the so-called physiologically functional food) and a... | 09/28/1999 |
| 5952384 | Method and composition for treating mammalian diseases caused by inflammatory response A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory response mediator which reduces ... | 09/14/1999 |
| 5939459 | Method and composition for treating mammalian disease caused by inflammatory response A method for treating emphysema and other disease states in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory response mediat... | 08/17/1999 |
| 5911992 | Method for controlling weight with hypericum perforatum and garcinia cambogia A method of controlling weight in mammals by orally administering to the mammal an amount of a pharmaceutical composition containing Hypericum perforatum or active components thereof effective to control the weight of the mammal is described. The pharmace... | 06/15/1999 |
| 5900435 | Composition, food product and uses of 3-guanidinopropionic acid The present invention provides a new composition, food product and uses for a known compound. More particularly, the present invention provides a new pharmaceutical composition containing 3-guanidinopropionic acid and a method of using 3-guanidinopropioni... | 05/04/1999 |
| 5891925 | Diagnostic method for assessing the serum cholesterol response to low diets A diagnostic method for assessing how a hypercholesterolemic person's serum cholesterol level will respond to a low total fat and saturated fat diet. The method involves defining a target cholesterol level, measuring a baseline level, feeding for a term o... | 04/06/1999 |
| 5877183 | Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists Provided are methods for the regulation and modification of lipid and glucose metabolism by administering to a subject a dopamine D1 agonist, optionally in combination with a dopamine D2 agonist, an alpha-1 adrenergic antagonist, an alpha-2 adrenergic ago... | 03/02/1999 |
| 5874522 | Crosslinked polymeric ammonium salts Disclosed are novel crosslinked polymeric ammonium salts wherein in said polymeric salt: about 25% or more of the segments which link ammonium nitrogen atoms are group Y wherein Y is an n-alkylene group or alkyl substituted n-alkylene group, wherein said ... | 02/23/1999 |
| 5869503 | Nicotine metabolites and human body weight A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicot... | 02/09/1999 |
| 5854255 | Therapeutic package for the long term reduction of body fat stores insulin resistance hyperinsulinemia and hyperglycemia in vertebrates A therapeutic package for dispensing to, or for use in dispensing to, a vertebrate being treated for a metabolic condition selected from the group consisting of obesity, insulin resistance, hyperinsulinemia, and hyperglycemia comprising one or more unit d... | 12/29/1998 |
| 5847008 | Method of treating diabetes and related disease states The instant invention is concerned with acetylphenols which are useful as antiobesity and antidiabetic compounds. Compositions and methods for the use of the compounds in the treatment of diabetes and obesity and for lowering or modulating triglyceride le... | 12/08/1998 |
| 5843476 | Slimming composition for topical treatment, containing two types of liposomes, and use thereof Compositions containing a first dispersion of lipid vesicles which are capable of penetrating into the deep layers of the skin and which contain at least one active agent chosen from lipolytic agents, draining agents and firming agents, for treating these... | 12/01/1998 |
| 5830909 | Angiotensin (AII) antagonists as inhibitors of the growth of adipose tissue The invention is a method of using Angiotensin (AII) Antagonists as inhibitors of the growth of adipose tissue, reducing adipocyte growth and body weight gain.... | 11/03/1998 |
| 5830895 | Methods for the determination and adjustment of prolactin daily rhythms Methods for detecting abnormalities in prolactin daily rhythms of a subject are provided. Prolactin levels of a subject are compared to levels of healthy subjects and based on the comparison a determination is made of the adjustments necessary to normaliz... | 11/03/1998 |
| 5824668 | Formulation for administration of steroid compounds Disclosed are compositions including at least one 5ଲ steroid and an amorphous cyclodextrin. Also disclosed are methods for treating a condition such as obesity, diabetes syndrome, diabetes-associated hypercorticoidism, combinations thereof, and anem... | 10/20/1998 |
| 5817689 | Indole derivatives having a 2-phenyl-ethanolamino-substituted lower alkyl group at the 2-or 3-position thereof An indole derivative of the formula: ##STR1## wherein R1 is lower alkoxy, lower alkoxycarbonyl-lower alkoxy, carboxy-lower alkoxy, lower alkoxycarbonyl, phenyl-lower alkoxy, lower alkyl being optionally substituted by hydroxy, di-lower ... | 10/06/1998 |
| 5795880 | Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent The invention describes a method and composition for treating obesity or related disorders in animals using an anorectic agent and dehydroepiandrosterone (DHEA). The composition effectively diminishes caloric intake, may alter metabolism, weight gain, or ... | 08/18/1998 |
